486675104	486675104	CD	B-NP	O
|	|	NN	I-NP	O
SH	SH	NN	I-NP	O
|	|	NN	I-NP	O
70102857	70102857	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
1854897	1854897	CD	B-NP	O
|	|	CC	I-NP	O
11/16/2006	11/16/2006	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
UROSEPSIS	UROSEPSIS	NNP	I-NP	O
,	,	,	O	O
ATRIAL	ATRIAL	NNP	B-NP	O
FIBRILLATION	FIBRILLATION	NNP	I-NP	O
|	|	NNP	I-NP	O
Unsigned	Unsigned	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
3/15/2006	3/15/2006	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Unsigned	Unsigned	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
7/27/2006	7/27/2006	CD	B-NP	O
ATTENDING	ATTENDING	NN	I-NP	O
:	:	:	O	O
PROWELL	PROWELL	NN	B-NP	O
,	,	,	O	O
RODRIGO	RODRIGO	NNP	B-NP	O
TYLER	TYLER	NNP	I-NP	O
M.D.	M.D.	NNP	I-NP	O
SERVICE	SERVICE	NNP	I-NP	O
:	:	:	O	O
GMS	GMS	NNP	B-NP	O
Ank	Ank	NNP	I-NP	O
Thay	Thay	NNP	I-NP	O
Nage	Nage	NNP	I-NP	O
intern	intern	NN	I-NP	O
.	.	.	O	O

CHIEF	CHIEF	NN	B-NP	B-protein
COMPLAINT	COMPLAINT	NN	I-NP	O
:	:	:	O	O
Seizure	Seizure	NN	B-NP	O
and	and	CC	I-NP	O
urosepsis	urosepsis	NN	I-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
75-year-old	75-year-old	JJ	I-NP	O
female	female	NN	I-NP	O
with	with	IN	B-PP	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
left	left	JJ	B-NP	O
MCA	MCA	NNP	I-NP	O
stroke	stroke	NN	I-NP	O
with	with	IN	B-PP	O
residual	residual	JJ	B-NP	O
right-sided	right-sided	JJ	I-NP	O
weakness	weakness	NN	I-NP	O
,	,	,	O	O
vascular	vascular	JJ	B-NP	O
dementia	dementia	NN	I-NP	O
,	,	,	O	O
insulin-dependent	insulin-dependent	JJ	B-NP	O
diabetes	diabete	NNS	I-NP	O
,	,	,	O	O
CAD	CAD	NN	B-NP	O
with	with	IN	B-PP	O
recent	recent	JJ	B-NP	O
admission	admission	NN	I-NP	O
for	for	IN	B-PP	O
proteus	proteus	NN	B-NP	O
UTI	UTI	NN	I-NP	O
,	,	,	O	O
admitted	admit	VBN	B-VP	O
with	with	IN	B-PP	O
mental	mental	JJ	B-NP	O
status	status	NN	I-NP	O
changes	change	NNS	I-NP	O
,	,	,	O	O
possible	possible	JJ	B-NP	O
tonic-clonic	tonic-clonic	JJ	I-NP	O
seizure	seizure	NN	I-NP	O
,	,	,	O	O
new	new	JJ	B-NP	O
atrial	atrial	JJ	I-NP	O
fibrillation	fibrillation	NN	I-NP	O
with	with	IN	B-PP	O
RVR	RVR	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
hypotension	hypotension	NN	B-NP	O
in	in	IN	B-PP	O
setting	setting	NN	B-NP	O
of	of	IN	B-PP	O
presumed	presume	VBN	B-NP	O
urosepsis	urosepsis	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
presented	present	VBD	B-VP	O
from	from	IN	B-PP	O
her	her	PRP$	B-NP	O
nursing	nursing	NN	I-NP	O
home	home	NN	I-NP	O
on	on	IN	B-PP	O
responses	response	NNS	B-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
witness	witness	NN	I-NP	O
seizure	seizure	NN	I-NP	O
activity	activity	NN	I-NP	O
and	and	CC	O	O
new	new	JJ	B-NP	O
onset	onset	NN	I-NP	O
atrial	atrial	JJ	I-NP	O
fibrillation	fibrillation	NN	I-NP	O
with	with	IN	B-PP	O
RVR	RVR	NN	B-NP	B-protein
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
recently	recently	RB	B-VP	O
admitted	admit	VBN	I-VP	O
on	on	IN	B-PP	O
10/22	10/22	CD	B-NP	O
with	with	IN	B-PP	O
proteus	proteus	NN	B-NP	O
UTI	UTI	NN	I-NP	O
requiring	require	VBG	B-VP	O
intubation	intubation	NN	B-NP	O
,	,	,	O	O
discharged	discharge	VBN	B-VP	O
to	to	TO	B-PP	O
rehabilitation	rehabilitation	NN	B-NP	O
and	and	CC	O	O
extensive	extensive	JJ	B-NP	O
courses	course	NNS	I-NP	O
of	of	IN	B-PP	O
cefpodoxime	cefpodoxime	NN	B-NP	O
.	.	.	O	O

As	As	IN	B-PP	O
per	per	IN	B-PP	O
the	the	DT	B-NP	O
EMS	EMS	NNP	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
tonic-clonic	tonic-clonic	JJ	B-NP	O
seizure	seizure	NN	I-NP	O
activity	activity	NN	I-NP	O
with	with	IN	B-PP	O
tachycardiac	tachycardiac	NN	B-NP	O
to	to	TO	B-PP	O
180s	180s	CD	B-NP	O
and	and	CC	O	O
desaturated	desaturate	VBN	B-VP	O
to	to	TO	B-PP	O
70	70	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

Notable	Notable	JJ	B-NP	O
studies	study	NNS	I-NP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
,	,	,	O	O
chest	chest	NN	B-NP	O
x-ray	x-ray	NN	I-NP	O
without	without	IN	B-PP	O
obvious	obvious	JJ	B-NP	O
infiltrate	infiltrate	NN	I-NP	O
,	,	,	O	O
head	head	NN	B-NP	O
CT	CT	NN	I-NP	O
without	without	IN	B-PP	O
acute	acute	JJ	B-NP	O
changes	change	NNS	I-NP	O
or	or	CC	O	O
left	leave	VBD	B-VP	O
MCA	MCA	NNP	B-NP	O
territory	territory	NN	I-NP	O
infarct	infarct	NN	I-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
.	.	.	O	O

Urinalysis	Urinalysis	NN	B-NP	O
is	be	VBZ	B-VP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
grossly	grossly	RB	B-NP	O
infected	infected	JJ	I-NP	O
urine	urine	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
MICU	MICU	NN	I-NP	B-DNA
where	where	WRB	B-ADVP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
aggressively	aggressively	RB	I-VP	O
resuscitated	resuscitate	VBN	I-VP	O
with	with	IN	B-PP	O
normalization	normalization	NN	B-NP	O
of	of	IN	B-PP	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
urine	urine	NN	I-NP	O
culture	culture	NN	I-NP	O
grew	grow	VBD	B-VP	O
enterococcus	enterococcus	NN	B-NP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
ceftazidime	ceftazidime	NN	B-NP	O
and	and	CC	I-NP	O
vancomycin	vancomycin	NN	I-NP	O
given	give	VBN	B-VP	O
her	her	PRP$	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
MRSA	MRSA	NN	B-NP	B-protein
and	and	CC	I-NP	O
proteus	proteus	NN	I-NP	O
UTI	UTI	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
weight	weight	NN	B-NP	O
controlled	control	VBN	B-VP	O
with	with	IN	B-PP	O
IV	IV	CD	B-NP	O
Lopressor	Lopressor	NN	I-NP	O
and	and	CC	O	O
transferred	transfer	VBN	B-VP	O
to	to	TO	B-PP	O
GMS	GMS	NN	B-NP	O
service	service	NN	I-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
As	As	IN	B-SBAR	O
follows	follow	VBZ	B-VP	O
,	,	,	O	O
left	left	JJ	B-NP	O
MCA	MCA	NNP	I-NP	O
stroke	stroke	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
resulted	result	VBD	B-VP	O
in	in	IN	B-PP	O
visible	visible	JJ	B-NP	O
right-sided	right-sided	JJ	I-NP	O
weakness	weakness	NN	I-NP	O
and	and	CC	I-NP	O
dysarthria	dysarthria	NN	I-NP	O
,	,	,	O	O
insulin-dependent	insulin-dependent	JJ	B-NP	O
diabetes	diabete	NNS	I-NP	O
,	,	,	O	O
neuropathy	neuropathy	NN	B-NP	O
,	,	,	O	O
nephropathy	nephropathy	NN	B-NP	O
,	,	,	O	O
CAD	CAD	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
MIBI	MIBI	NNP	I-NP	O
was	be	VBD	B-VP	O
on	on	IN	B-PP	O
done	do	VBN	B-VP	O
in	in	IN	B-PP	O
3/3	3/3	CD	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
reversible	reversible	JJ	I-NP	O
anteroapical	anteroapical	JJ	I-NP	O
defect	defect	NN	I-NP	O
,	,	,	O	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
peripheral	peripheral	JJ	B-NP	O
vascular	vascular	JJ	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	VBD	B-VP	O
right	right	JJ	B-NP	O
fifth	fifth	JJ	I-NP	O
toe	toe	NN	I-NP	O
amputation	amputation	NN	I-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
left	leave	VBD	B-VP	O
fem	fem	NN	B-NP	O
bypass	bypass	NN	I-NP	O
,	,	,	O	O
also	also	RB	B-ADVP	O
vascular	vascular	JJ	B-NP	O
dementia	dementia	NN	I-NP	O
,	,	,	O	O
chronic	chronic	JJ	B-NP	O
kidney	kidney	NN	I-NP	O
disease	disease	NN	I-NP	O
with	with	IN	B-PP	O
creatinines	creatinine	NNS	B-NP	O
of	of	IN	B-PP	O
1.8-2	1.8-2	CD	B-NP	O
,	,	,	O	O
GERD	GERD	NNP	B-NP	O
,	,	,	O	O
cataracts	cataract	NNS	B-NP	O
,	,	,	O	O
depression	depression	NN	B-NP	O
,	,	,	O	O
venous	venous	JJ	B-NP	O
insufficiency	insufficiency	NN	I-NP	O
with	with	IN	B-PP	O
right	right	JJ	B-NP	O
heel	heel	NN	I-NP	O
ulcer	ulcer	NN	I-NP	O
,	,	,	O	O
left	leave	VBD	B-VP	O
heel	heel	NN	B-NP	O
ulcer	ulcer	NN	I-NP	O
with	with	IN	B-PP	O
underlying	underlie	VBG	B-VP	O
osteomyelitis	osteomyelitis	NN	B-NP	O
,	,	,	O	O
angina	angina	NN	B-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
right	right	JJ	I-NP	O
mastectomy	mastectomy	NN	I-NP	O
for	for	IN	B-PP	O
distant	distant	JJ	B-NP	O
breast	breast	NN	I-NP	O
cancer	cancer	NN	I-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
cholecystectomy	cholecystectomy	NN	I-NP	O
,	,	,	O	O
TAH	TAH	NN	B-NP	B-protein
,	,	,	O	O
open	open	JJ	B-NP	O
distal	distal	JJ	I-NP	O
right	right	JJ	I-NP	O
tibial	tibial	JJ	I-NP	O
fracture	fracture	NN	I-NP	O
in	in	IN	B-PP	O
11/24	11/24	CD	B-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	JJ	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
:	:	:	O	O
Afebrile	Afebrile	NN	B-NP	O
,	,	,	O	O
pulse	pulse	NN	B-NP	O
83	83	CD	I-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
is	be	VBZ	B-VP	O
ranging	range	VBG	I-VP	O
from	from	IN	B-PP	O
110-150/70	110-150/70	CD	B-NP	O
-80	-80	NN	I-NP	O
,	,	,	O	O
O2	O2	NN	B-NP	O
sat	sit	VBD	B-VP	O
100	100	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
regular	regular	JJ	B-NP	O
rate	rate	NN	I-NP	O
and	and	CC	I-NP	O
rhythm	rhythm	NN	I-NP	O
in	in	IN	B-PP	O
sinus	sinus	NN	B-NP	O
.	.	.	O	O

Extremity	Extremity	NN	B-NP	O
exam	exam	NN	I-NP	O
is	be	VBZ	B-VP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
2	2	CD	B-NP	O
+	+	SYM	I-NP	O
edema	edema	NN	I-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
right	right	RB	B-ADVP	O
greater	great	JJR	I-ADVP	O
than	than	IN	B-PP	O
left	left	JJ	B-NP	O
,	,	,	I-NP	O
upper	upper	JJ	I-NP	O
arm	arm	NN	I-NP	O
erythema	erythema	NN	I-NP	O
near	near	IN	B-PP	O
her	her	PRP$	B-NP	O
PICC	PICC	NN	I-NP	B-DNA
site	site	NN	I-NP	I-DNA
,	,	,	O	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
not	not	RB	O	O
new	new	JJ	B-ADJP	O
.	.	.	O	O

Heel	Heel	NN	B-NP	O
dressings	dressing	NNS	I-NP	O
clean	clean	JJ	B-ADJP	O
,	,	,	O	O
dry	dry	JJ	B-ADJP	O
,	,	,	O	O
and	and	CC	O	O
intact	intact	JJ	B-ADJP	O
.	.	.	O	O

Neuro	Neuro	NN	B-NP	O
exam	exam	NN	I-NP	O
was	be	VBD	B-VP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
baseline	baseline	NN	B-NP	O
right	right	JJ	I-NP	O
hemiparesis	hemiparesis	NN	I-NP	O
and	and	CC	I-NP	O
aphasia	aphasia	NN	I-NP	O
.	.	.	O	O

Pupils	Pupil	NNS	B-NP	O
of	of	IN	B-PP	O
left	left	NN	B-NP	O
are	be	VBP	B-VP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
right	right	JJ	B-ADJP	O
.	.	.	O	O

Left	Left	NNP	B-NP	O
is	be	VBZ	B-VP	O
surgical	surgical	JJ	B-NP	O
pupils	pupil	NNS	I-NP	O
and	and	CC	O	O
both	both	DT	O	O
reactive	reactive	JJ	O	O
.	.	.	O	O

At	At	IN	B-PP	O
baseline	baseline	NN	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
has	have	VBZ	B-VP	O
repetitive	repetitive	JJ	B-NP	O
speech	speech	NN	I-NP	O
and	and	CC	O	O
also	also	RB	B-VP	O
had	have	VBD	I-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
screaming	scream	VBG	B-VP	O
when	when	WRB	B-ADVP	O
wake	wake	NN	B-NP	O
at	at	IN	B-PP	O
night	night	NN	B-NP	O
that	that	WDT	B-NP	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
sued	sue	VBN	I-VP	O
by	by	IN	B-PP	O
direction	direction	NN	B-NP	O
with	with	IN	B-PP	O
people	people	NNS	B-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
BY	BY	NNP	I-NP	O
PROBLEMS	PROBLEMS	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

ID	ID	NN	B-NP	O
:	:	:	O	O
Admitted	Admit	VBN	B-VP	O
with	with	IN	B-PP	O
urosepsis	urosepsis	NN	B-NP	O
,	,	,	O	O
afebrile	afebrile	NN	B-NP	O
,	,	,	O	O
leukocytosis	leukocytosis	NN	B-NP	O
resolving	resolve	VBG	B-VP	O
,	,	,	O	O
and	and	CC	O	O
urine	urine	NN	B-NP	B-cell_line
culture	culture	NN	I-NP	I-cell_line
from	from	IN	B-PP	O
admit	admit	NN	B-NP	O
not	not	RB	O	O
growing	grow	VBG	B-NP	O
enterococcus-VRE	enterococcus-VRE	NN	I-NP	O
on	on	IN	B-PP	O
IV	IV	CD	B-NP	O
Linezolid	Linezolid	NN	I-NP	O
for	for	IN	B-PP	O
better	good	JJR	B-NP	O
absorption	absorption	NN	I-NP	O
.	.	.	O	O

Instruction	Instruction	NN	B-NP	O
:	:	:	O	O
Finished	Finish	VBN	B-NP	O
14-day	14-day	JJ	I-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
Linezolid	Linezolid	NN	B-NP	O
today	today	NN	I-NP	O
day	day	NN	I-NP	O
six	six	CD	I-NP	O
.	.	.	O	O

Renal	Renal	JJ	B-NP	O
ultrasound	ultrasound	NN	I-NP	O
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
for	for	IN	B-PP	O
hydro	hydro	NN	B-NP	O
,	,	,	O	O
patient	patient	NN	B-NP	O
incontinent	incontinent	NN	I-NP	O
,	,	,	O	O
passing	pass	VBG	B-VP	O
urine	urine	NN	B-NP	O
,	,	,	O	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
afebrile	afebrile	RB	B-ADVP	O
with	with	IN	B-PP	O
normal	normal	JJ	B-NP	O
white	white	JJ	I-NP	O
blood	blood	NN	I-NP	O
cell	cell	NN	I-NP	O
count	count	NN	I-NP	O
and	and	CC	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

CV	CV	NN	B-NP	O
:	:	:	O	O
Ischemia	Ischemia	NN	B-NP	O
:	:	:	O	O
History	History	NN	B-NP	O
of	of	IN	B-PP	O
CAD	CAD	NN	B-NP	B-protein
,	,	,	O	O
enzymes	enzyme	VBZ	B-VP	O
negative	negative	JJ	B-NP	B-protein
x3	x3	NN	I-NP	I-protein
here	here	RB	B-ADVP	O
.	.	.	O	O

Had	Have	VBD	B-VP	O
ST	ST	JJ	B-NP	O
depressions	depression	NNS	I-NP	O
on	on	IN	B-PP	O
EKG	EKG	NN	B-NP	B-protein
initially	initially	RB	B-ADVP	O
.	.	.	O	O

EKG	EKG	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
normal	normal	JJ	B-ADJP	O
since	since	IN	B-SBAR	O
continue	continue	JJ	B-NP	O
aspirin	aspirin	NN	I-NP	O
,	,	,	O	O
statin	statin	NN	B-NP	B-protein
beta-blocker	beta-blocker	NN	I-NP	I-protein
,	,	,	O	O
pump	pump	NN	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
known	known	JJ	I-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
CHF	CHF	NN	B-NP	B-protein
,	,	,	O	O
EF	EF	NN	B-NP	O
55	55	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
total	total	JJ	B-NP	O
body	body	NN	I-NP	O
fluid	fluid	NN	I-NP	O
overloaded	overload	VBD	B-VP	O
.	.	.	O	O

We	We	PRP	B-NP	O
have	have	VBP	B-VP	O
restarted	restart	VBN	I-VP	O
Lasix	Lasix	NNP	B-NP	O
20	20	CD	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressures	pressure	NNS	I-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
elevated	elevate	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
treated	treat	VBN	I-VP	O
right	right	RB	B-ADVP	O
now	now	RB	I-ADVP	O
with	with	IN	B-PP	O
Lopressor	Lopressor	NN	B-NP	O
,	,	,	O	O
Catapres	Catapre	VBZ	B-VP	O
patch	patch	NN	B-NP	O
versus	versus	IN	B-PP	O
currently	currently	RB	B-NP	O
12.5	12.5	CD	I-NP	O
mg	mg	NN	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
Instruction	Instruction	NN	I-NP	O
:	:	:	O	O
Please	Please	NN	B-NP	O
titrate	titrate	NN	I-NP	O
as	as	RB	O	O
necessary	necessary	JJ	B-ADJP	O
to	to	TO	B-PP	O
home	home	NN	B-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
Toprol	Toprol	NN	B-NP	O
XL	XL	NN	I-NP	O
50	50	CD	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

Instruction	Instruction	NN	B-NP	O
:	:	:	O	O
Continue	Continue	JJ	B-NP	O
clonidine	clonidine	NN	I-NP	O
patch	patch	NN	I-NP	O
,	,	,	O	O
add	add	VB	B-VP	O
Imdur	Imdur	NNP	B-NP	O
as	as	IN	B-PP	O
necessary	necessary	JJ	B-ADJP	O
.	.	.	O	O

Rate	Rate	NN	B-NP	O
:	:	:	O	O
Atrial	Atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
with	with	IN	B-PP	O
RVR	RVR	NN	B-NP	B-protein
visit	visit	NN	I-NP	O
admit	admit	NN	I-NP	O
likely	likely	RB	B-ADJP	O
secondary	secondary	JJ	I-ADJP	O
to	to	TO	B-PP	O
sepsis	sepsis	NN	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
in	in	IN	B-PP	O
normal	normal	JJ	B-NP	O
sinus	sinus	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
Coumadin	Coumadin	NN	I-NP	O
now	now	RB	B-ADVP	O
.	.	.	O	O

Rate	Rate	NN	B-NP	O
controlled	control	VBN	B-VP	O
with	with	IN	B-PP	O
IV	IV	CD	B-NP	O
Lopressor	Lopressor	NN	I-NP	O
and	and	CC	B-PP	O
on	on	IN	B-PP	O
aspirin	aspirin	NN	B-NP	O
81	81	CD	I-NP	O
.	.	.	O	O

If	If	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
in	in	IN	B-PP	O
paroxysmal	paroxysmal	JJ	B-NP	O
atrial	atrial	JJ	I-NP	O
fibrillation	fibrillation	NN	I-NP	O
can	can	MD	B-VP	O
consider	consider	VB	I-VP	O
increasing	increase	VBG	B-NP	O
to	to	TO	B-PP	O
aspirin	aspirin	NN	B-NP	O
325	325	CD	I-NP	O
mg	mg	NN	I-NP	O
later	later	RB	B-ADVP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
week	week	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Neuro	Neuro	NN	B-NP	O
:	:	:	O	O
Possible	Possible	JJ	B-NP	O
seizures	seizure	NNS	I-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
urosepsis	urosepsis	NN	B-NP	O
.	.	.	O	O

EEG	EEG	NN	B-NP	O
negative	negative	JJ	B-ADJP	O
for	for	IN	B-PP	O
epileptic	epileptic	JJ	B-NP	O
form	form	NN	I-NP	O
activity	activity	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
currently	currently	RB	B-ADVP	O
on	on	IN	B-PP	O
Dilantin	Dilantin	NN	B-NP	B-protein
for	for	IN	B-PP	O
goal	goal	NN	B-NP	O
equal	equal	JJ	B-ADJP	O
to	to	TO	B-PP	O
10	10	CD	B-NP	O
,	,	,	O	O
last	last	JJ	B-NP	O
level	level	NN	I-NP	O
was	be	VBD	B-VP	O
8.7	8.7	CD	B-NP	O
corrected	correct	VBN	B-VP	O
for	for	IN	B-PP	O
albumin	albumin	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
13.5	13.5	CD	B-NP	O
,	,	,	O	O
currently	currently	RB	B-ADVP	O
on	on	IN	B-PP	O
Dilantin	Dilantin	NN	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
Instructions	Instruction	NNS	I-NP	O
:	:	:	O	O
We	We	PRP	B-NP	O
checked	check	VBD	B-VP	O
Dilantin	Dilantin	NN	B-NP	B-protein
level	level	NN	I-NP	O
in	in	IN	B-PP	O
one	one	CD	B-NP	O
week	week	NN	I-NP	O
-	-	HYPH	O	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
CVA	CVA	NN	B-NP	B-protein
,	,	,	O	O
left	leave	VBD	B-VP	O
MCA	MCA	NNP	B-NP	O
stroke	stroke	NN	I-NP	O
,	,	,	O	O
has	have	VBZ	B-VP	O
right-sided	right-sided	JJ	B-NP	O
weakness	weakness	NN	I-NP	O
not	not	RB	B-ADJP	O
new	new	JJ	I-ADJP	O
.	.	.	O	O

Question	Question	NN	B-NP	O
of	of	IN	B-PP	O
new	new	JJ	B-NP	O
stroke	stroke	NN	I-NP	O
clinically	clinically	RB	B-ADVP	O
on	on	IN	B-PP	O
11/24	11/24	NN	B-NP	O
was	be	VBD	B-VP	O
seen	see	VBN	I-VP	O
by	by	IN	B-PP	O
Neurology	Neurology	NNP	B-NP	O
,	,	,	O	O
but	but	CC	O	O
they	they	PRP	B-NP	O
think	think	VBP	B-VP	O
most	most	RBS	B-ADVP	O
likely	likely	RB	I-ADVP	O
just	just	RB	B-NP	O
Haldol	Haldol	NN	I-NP	O
effect	effect	NN	I-NP	O
and	and	CC	I-NP	O
type	type	NN	I-NP	O
of	of	IN	B-PP	O
old	old	JJ	B-NP	O
left	left	JJ	I-NP	O
MCA	MCA	NNP	I-NP	O
stroke	stroke	VBD	B-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
with	with	IN	B-PP	O
improved	improve	VBN	B-NP	O
exam	exam	NN	I-NP	O
in	in	IN	B-PP	O
7/28	7/28	CD	B-NP	O
,	,	,	O	O
so	so	IN	O	O
no	no	DT	B-NP	O
MRI	MRI	NN	I-NP	B-protein
indicated	indicate	VBD	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
future	future	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
does	do	VBZ	B-VP	O
require	require	VB	I-VP	O
MRI	MRI	NN	B-NP	B-protein
,	,	,	O	O
must	must	MD	B-VP	O
get	get	VB	I-VP	O
consent	consent	NN	B-NP	O
from	from	IN	B-PP	O
family	family	NN	B-NP	O
,	,	,	O	O
discussed	discuss	VBN	B-VP	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
orthopedist	orthopedist	NN	I-NP	O
and	and	CC	I-NP	O
radiology	radiology	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
pain	pain	NN	I-NP	O
is	be	VBZ	B-VP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
right	right	JJ	I-NP	O
foot	foot	NN	I-NP	O
and	and	CC	I-NP	O
contact	contact	NN	I-NP	O
Dr.	Dr.	NNP	I-NP	O
Julian	Julian	NNP	I-NP	O
E	E	NNP	I-NP	O
Charbonnel	Charbonnel	NNP	I-NP	O
from	from	IN	B-PP	O
ortho	ortho	JJ	B-NP	O
at	at	IN	B-PP	O
Blantonain	Blantonain	NNP	B-NP	O
Hospital	Hospital	NNP	I-NP	O
,	,	,	O	O
126-888-6789	126-888-6789	CD	B-NP	O
.	.	.	O	O

Mental	Mental	JJ	B-NP	O
status	status	NN	I-NP	O
remains	remain	VBZ	B-VP	O
poor	poor	JJ	B-ADJP	O
and	and	CC	O	O
per	per	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
husband	husband	NN	I-NP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
intermittently	intermittently	RB	B-ADJP	O
conversant	conversant	JJ	I-ADJP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
and	and	CC	O	O
occasionally	occasionally	RB	B-ADVP	O
screams	scream	NNS	B-NP	O
at	at	IN	B-PP	O
rehab	rehab	NN	B-NP	O
.	.	.	O	O

Give	Give	VB	B-VP	O
Haldol	Haldol	NN	B-NP	O
if	if	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
inconsolable	inconsolable	JJ	B-ADJP	O
.	.	.	O	O

Home	Home	NN	B-NP	O
regimen	regimen	NN	I-NP	O
was	be	VBD	B-VP	O
Remeron	Remeron	NNP	B-NP	O
,	,	,	O	O
Prozac	Prozac	NNP	B-NP	O
,	,	,	O	O
and	and	CC	O	O
Seroquel	Seroquel	NNP	B-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
have	have	VBP	B-VP	O
held	hold	VBN	I-VP	O
the	the	DT	B-NP	O
Remeron	Remeron	NNP	I-NP	O
to	to	TO	B-VP	O
do	do	VB	I-VP	O
its	its	PRP$	B-NP	O
interaction	interaction	NN	I-NP	O
with	with	IN	B-PP	O
clonidine	clonidine	NN	B-NP	O
and	and	CC	O	O
it	it	PRP	B-NP	O
is	be	VBZ	B-VP	O
decreased	decrease	VBN	I-VP	O
after	after	IN	B-SBAR	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
the	the	DT	B-NP	O
clonidine	clonidine	NN	I-NP	O
for	for	IN	B-PP	O
hypertension	hypertension	NN	B-NP	O
and	and	CC	O	O
also	also	RB	B-ADVP	O
had	have	VBD	B-VP	O
held	hold	VBN	I-VP	O
Prozac	Prozac	NNP	B-NP	O
which	which	WDT	B-NP	O
has	have	VBZ	B-VP	O
caused	cause	VBN	I-VP	O
serotonin	serotonin	NN	B-NP	O
syndrome	syndrome	NN	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
Linezolid	Linezolid	NN	I-NP	O
on	on	IN	B-PP	O
board	board	NN	B-NP	O
.	.	.	O	O

Instructions	Instruction	NNS	B-NP	O
:	:	:	O	O
Consider	Consider	VB	B-VP	O
restarting	restart	VBG	I-VP	O
these	these	DT	B-NP	O
antidepressants	antidepressant	NNS	I-NP	O
once	once	RB	B-ADVP	O
off	off	IN	B-PP	O
Linezolid	Linezolid	NNP	B-NP	O
.	.	.	O	O

Instructions	Instruction	NNS	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
takes	take	VBZ	B-VP	O
meds	med	NNS	B-NP	O
.	.	.	O	O

If	If	IN	B-SBAR	O
husband	husband	NN	B-NP	O
around	around	RB	B-ADVP	O
so	so	RB	B-ADVP	O
may	may	MD	B-VP	O
want	want	VB	I-VP	O
at	at	IN	B-PP	O
time	time	NN	B-NP	O
p.o.	p.o.	FW	B-NP	O
meds	med	NNS	I-NP	O
around	around	IN	B-PP	O
this	this	DT	B-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Heme	Heme	NN	B-NP	B-protein
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
PF4	PF4	NN	B-NP	B-protein
positive	positive	JJ	B-ADJP	O
,	,	,	O	O
but	but	CC	O	O
platelets	platelet	NNS	B-NP	B-cell_type
are	be	VBP	B-VP	O
normal	normal	JJ	B-ADJP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Pulm	Pulm	NNP	B-NP	O
:	:	:	O	O
Sating	Sate	VBG	B-VP	O
well	well	RB	B-ADVP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
.	.	.	O	O

Normal	Normal	JJ	B-NP	O
chest	chest	NN	I-NP	O
x-ray	x-ray	NN	I-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Endo	Endo	NNP	B-NP	O
:	:	:	O	O
History	History	NN	B-NP	O
of	of	IN	B-PP	O
insulin-dependent	insulin-dependent	JJ	B-NP	O
diabetes	diabete	NNS	I-NP	O
,	,	,	O	O
on	on	IN	B-PP	O
insulin	insulin	NN	B-NP	O
and	and	CC	I-NP	O
glipizide	glipizide	NN	I-NP	O
on	on	IN	B-PP	O
rehab	rehab	NN	B-NP	O
and	and	CC	B-PP	O
now	now	RB	B-ADVP	O
on	on	IN	B-PP	O
insulin	insulin	NN	B-NP	B-protein
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
.	.	.	O	O

Has	Has	NNP	B-NP	O
recently	recently	RB	B-ADVP	O
started	start	VBD	B-VP	O
p.o.	p.o.	FW	B-NP	O
feeding	feeding	NN	I-NP	O
.	.	.	O	O

Currently	Currently	RB	B-ADVP	O
on	on	IN	B-PP	O
insulin	insulin	NN	B-NP	B-protein
sliding	slide	VBG	B-VP	O
scales	scale	NNS	B-NP	O
for	for	IN	B-PP	O
transfer	transfer	NN	B-NP	O
.	.	.	O	O

Instructions	Instruction	NNS	B-NP	O
:	:	:	O	O
Conversion	Conversion	NN	B-NP	O
to	to	TO	B-VP	O
glipizide	glipizide	VB	I-VP	O
40	40	CD	B-NP	O
nightly	nightly	RB	B-ADVP	O
as	as	IN	B-PP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
with	with	IN	B-PP	O
increasing	increase	VBG	B-NP	O
p.o.	p.o.	FW	I-NP	O
intake	intake	NN	I-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

FEN	FEN	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
passed	pass	VBD	B-VP	O
speech	speech	NN	B-NP	O
and	and	CC	I-NP	O
swallow	swallow	NN	I-NP	O
.	.	.	O	O

Currently	Currently	RB	B-ADVP	O
on	on	IN	B-PP	O
prune	prune	NN	B-NP	O
,	,	,	O	O
honey	honey	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
liquids	liquid	NNS	B-NP	O
therefore	therefore	RB	B-ADVP	O
now	now	RB	B-ADVP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

Prophylaxis	Prophylaxis	NN	B-NP	O
:	:	:	O	O
On	On	IN	B-PP	O
Nexium	Nexium	NN	B-NP	O
,	,	,	O	O
off	off	RB	B-ADVP	O
Lovenox	Lovenox	NNP	B-NP	O
for	for	IN	B-PP	O
transfer	transfer	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
full	full	JJ	B-NP	O
code	code	NN	I-NP	O
.	.	.	O	O

HOME	HOME	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
Aspirin	Aspirin	NN	B-NP	O
81	81	CD	B-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
Toprol	Toprol	NNP	B-NP	O
XL	XL	NNP	I-NP	O
50	50	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	JJ	I-NP	O
,	,	,	O	O
multivitamins	multivitamin	NNS	B-NP	O
,	,	,	O	O
Artificial	Artificial	NNP	B-NP	O
Tears	Tears	NNP	I-NP	O
,	,	,	O	O
mirtazapine	mirtazapine	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
nightly	nightly	RB	B-ADVP	O
,	,	,	O	O
glipizide	glipizide	NN	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
nightly	nightly	RB	B-ADVP	O
,	,	,	O	O
Xalatan	Xalatan	NN	B-NP	O
one	one	CD	I-NP	O
drop	drop	NN	I-NP	O
in	in	IN	B-PP	O
each	each	DT	B-NP	O
eye	eye	NN	I-NP	O
nightly	nightly	RB	B-ADVP	O
,	,	,	O	O
Seroquel	Seroquel	NNP	B-NP	O
50	50	CD	I-NP	O
mg	mg	NN	I-NP	O
q.p.m.	q.p.m.	NN	I-NP	O
,	,	,	O	O
20	20	CD	B-NP	O
mg	mg	NN	I-NP	O
q.a.m.	q.a.m.	NN	I-NP	O
,	,	,	O	O
Prilosec	Prilosec	NNP	B-NP	O
20	20	CD	I-NP	O
,	,	,	O	O
hydrochlorothiazide	hydrochlorothiazide	NN	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
,	,	,	O	O
Lasix	Lasix	NNP	B-NP	O
20	20	CD	I-NP	O
,	,	,	O	O
Catapres	Catapre	VBZ	B-VP	O
patch	patch	NN	B-NP	O
every	every	DT	O	O
Thursday	Thursday	NNP	B-NP	O
,	,	,	O	O
Combivent	Combivent	NNP	B-NP	O
t.i.d.	t.i.d.	NNP	I-NP	O
,	,	,	O	O
Imdur	Imdur	NNP	B-NP	O
90	90	CD	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
Lipitor	Lipitor	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
nightly	nightly	RB	B-ADVP	O
,	,	,	O	O
Prozac	Prozac	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
nightly	nightly	RB	B-ADVP	O
,	,	,	O	O
Dulcolax	Dulcolax	NN	B-NP	O
nightly	nightly	RB	B-ADVP	O
,	,	,	O	O
Tylenol	Tylenol	NN	B-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
,	,	,	O	O
Colace	Colace	NNP	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
,	,	,	O	O
Sena	Sena	NNP	B-NP	O
,	,	,	O	O
Mycolog	Mycolog	NNP	B-NP	O
cream	cream	VBP	B-VP	O
to	to	TO	I-VP	O
groin	groin	VB	I-VP	O
b.i.d.	b.i.d.	NN	B-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
,	,	,	O	O
Mylanta	Mylanta	NNP	B-NP	O
one	one	CD	I-NP	O
to	to	TO	B-PP	O
two	two	CD	B-NP	O
nightly	nightly	RB	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
,	,	,	O	O
lorazepam	lorazepam	NN	B-NP	O
0.5	0.5	CD	I-NP	O
q.	q.	NN	I-NP	O
4	4	CD	B-NP	O
h.	h.	NN	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
ALLERGIES	ALLERGIES	NN	I-NP	O
:	:	:	O	O
Ace	Ace	NN	B-NP	O
inhibitors	inhibitor	NNS	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
gets	get	VBZ	B-VP	O
hyperkalemia	hyperkalemia	NN	B-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
As	As	IN	B-SBAR	O
follows	follow	VBZ	B-VP	O
,	,	,	O	O
Tylenol	Tylenol	NN	B-NP	O
650	650	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.	q.	NN	I-NP	O
6	6	CD	I-NP	O
h.	h.	NN	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
for	for	IN	B-PP	O
pain	pain	NN	B-NP	O
,	,	,	O	O
aspirin	aspirin	NN	B-NP	O
81	81	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
Dilantin	Dilantin	NNP	B-NP	O
15	15	CD	I-NP	O
mL	mL	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.	q.	NN	I-NP	O
4	4	CD	I-NP	O
h.	h.	NN	I-NP	O
upset	upset	JJ	I-NP	O
stomach	stomach	NN	I-NP	O
,	,	,	O	O
Artificial	Artificial	NNP	B-NP	O
Tears	Tear	VBZ	B-VP	O
one	one	CD	B-NP	O
drop	drop	NN	I-NP	O
in	in	IN	B-PP	O
each	each	DT	B-NP	O
eye	eye	NN	I-NP	O
at	at	IN	B-PP	O
night	night	NN	B-NP	O
,	,	,	O	O
aspart	aspart	RB	B-VP	O
sliding	slide	VBG	I-VP	O
scale	scale	NN	B-NP	O
subcutaneous	subcutaneous	JJ	B-ADJP	O
before	before	IN	B-PP	O
and	and	CC	I-PP	O
after	after	IN	I-PP	O
meals	meal	NNS	B-NP	O
,	,	,	O	O
Lipitor	Lipitor	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
Dulcolax	Dulcolax	NN	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
bedtime	bedtime	NN	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
constipation	constipation	NN	I-NP	O
,	,	,	O	O
Catapres	Catapre	VBZ	B-VP	O
patch	patch	NN	B-NP	O
0.1	0.1	CD	I-NP	O
mg	mg	NN	I-NP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
topically	topically	RB	B-ADVP	O
changed	change	VBD	B-VP	O
every	every	DT	B-NP	O
week	week	NN	I-NP	O
,	,	,	O	O
Colace	Colace	NNP	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
Nexium	Nexium	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
,	,	,	O	O
Lasix	Lasix	NNP	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
Combivent	Combivent	NNP	B-NP	O
two	two	CD	I-NP	O
puffs	puff	NNS	I-NP	O
inhaled	inhale	VBD	B-VP	O
q.i.d.	q.i.d.	NN	B-NP	O
,	,	,	O	O
lactulose	lactulose	RB	B-NP	O
30	30	CD	I-NP	O
mL	mL	NN	I-NP	O
p.o.	p.o.	FW	B-NP	O
q.i.d.	q.i.d.	FW	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
constipation	constipation	NN	I-NP	O
,	,	,	O	O
Xalatan	Xalatan	NN	B-NP	O
one	one	CD	I-NP	O
drop	drop	NN	I-NP	O
in	in	IN	B-PP	O
each	each	DT	B-NP	O
eye	eye	NN	I-NP	O
bedtime	bedtime	NN	I-NP	O
,	,	,	O	O
Nasalide	Nasalide	NN	B-NP	O
600	600	CD	I-NP	O
mg	mg	NN	I-NP	O
IV	IV	CD	B-NP	O
q.	q.	NN	I-NP	O
12	12	CD	B-NP	O
h.	h.	NN	I-NP	O
,	,	,	O	O
Ativan	Ativan	IN	B-ADVP	O
0.5	0.5	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-NP	O
q.i.d.	q.i.d.	FW	I-NP	O
p.r.n.	p.r.n.	FW	I-NP	O
anxiety	anxiety	NN	I-NP	O
,	,	,	O	O
Maalox	Maalox	NNP	B-NP	O
one	one	CD	I-NP	O
to	to	TO	B-PP	O
two	two	CD	B-NP	O
tablets	tablet	NNS	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
6	6	CD	I-NP	O
h.	h.	NN	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
upset	upset	NN	I-NP	O
stomach	stomach	NN	I-NP	O
,	,	,	O	O
milk	milk	NN	B-NP	O
of	of	IN	B-PP	O
magnesia	magnesia	NN	B-NP	O
30	30	CD	I-NP	O
mL	mL	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
daily	daily	JJ	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
constipation	constipation	NN	I-NP	O
,	,	,	O	O
Lopressor	Lopressor	NN	B-NP	O
12.5	12.5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
t.i.d.	t.i.d.	FW	I-ADVP	O
hold	hold	VBP	B-VP	O
if	if	IN	B-SBAR	O
heart	heart	NN	B-NP	O
rate	rate	NN	I-NP	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
60	60	CD	I-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
less	less	JJR	B-ADJP	O
than	than	IN	B-PP	O
100	100	CD	B-NP	O
,	,	,	O	O
Mycolog	Mycolog	NNP	B-NP	O
topical	topical	JJ	I-NP	O
applied	apply	VBN	B-VP	O
to	to	TO	B-VP	O
groin	groin	VB	I-VP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
,	,	,	O	O
Dilantin	Dilantin	NNP	B-NP	O
300	300	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
Seroquel	Seroquel	NNP	B-NP	O
50	50	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.p.m.	q.p.m.	NN	I-NP	O
,	,	,	O	O
Sena	Sena	NNP	B-NP	O
liquid	liquid	VBD	B-VP	O
one	one	CD	B-NP	O
teaspoon	teaspoon	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
bedtime	bedtime	NN	I-NP	O
,	,	,	O	O
multivitamin	multivitamin	NN	B-NP	O
5	5	CD	I-NP	O
mL	mL	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

Holding	Hold	VBG	B-VP	O
the	the	DT	B-NP	O
following	follow	VBG	I-NP	O
medications	medication	NNS	I-NP	O
from	from	IN	B-PP	O
home	home	NN	B-NP	O
are	be	VBP	B-VP	O
Imdur	Imdur	NNP	B-NP	O
,	,	,	O	O
Remeron	Remeron	NNP	B-NP	O
,	,	,	O	O
and	and	CC	O	O
Prozac	Prozac	NN	B-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
following	follow	VBG	I-NP	O
medications	medication	NNS	I-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
titrated	titrate	VBN	I-VP	O
following	follow	VBG	B-PP	O
transfer	transfer	NN	B-NP	O
as	as	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
tolerates	tolerate	VBZ	B-VP	O
.	.	.	O	O

Titrate	Titrate	NN	B-NP	O
from	from	IN	B-PP	O
Lopressor	Lopressor	NN	B-NP	O
12.5	12.5	CD	I-NP	O
mg	mg	NN	I-NP	O
t.i.d.	t.i.d.	VBN	B-VP	O
to	to	TO	B-PP	O
Toprol	Toprol	NNP	B-NP	O
XL	XL	NNP	I-NP	O
50	50	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	I-NP	O
as	as	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
tolerates	tolerate	VBZ	B-VP	O
.	.	.	O	O

Change	Change	NN	B-NP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
from	from	IN	B-PP	O
insulin	insulin	NN	B-NP	B-protein
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
to	to	TO	B-VP	O
glipizide	glipizide	VB	I-VP	O
40	40	CD	B-NP	O
mg	mg	NN	I-NP	O
nightly	nightly	RB	B-ADVP	O
.	.	.	O	O

Restart	Restart	NNP	B-NP	O
hydrochlorothiazide	hydrochlorothiazide	NN	I-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	JJ	I-NP	O
and	and	CC	O	O
if	if	IN	B-SBAR	O
needed	need	VBN	B-VP	O
we	we	PRP	B-NP	O
start	start	VBP	B-VP	O
Imdur	Imdur	NNP	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
held	hold	VBN	I-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
Prozac	Prozac	NN	I-NP	O
again	again	RB	B-ADVP	O
for	for	IN	B-PP	O
possible	possible	JJ	B-NP	O
serotonin	serotonin	NN	I-NP	O
syndrome	syndrome	NN	I-NP	O
and	and	CC	I-NP	O
interaction	interaction	NN	I-NP	O
since	since	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
on	on	IN	B-PP	O
Linezolid	Linezolid	NN	B-NP	O
600	600	CD	I-NP	O
mg	mg	NN	I-NP	O
IV	IV	CD	B-NP	O
q.	q.	NN	I-NP	O
12	12	CD	B-NP	O
h.	h.	NN	I-NP	O
Also	Also	RB	B-VP	O
add	add	VB	I-VP	O
mirtazapine	mirtazapine	NN	B-NP	O
as	as	IN	B-PP	O
necessary	necessary	JJ	B-ADJP	O
,	,	,	O	O
but	but	CC	O	O
beware	beware	NN	B-NP	O
of	of	IN	B-PP	O
interaction	interaction	NN	B-NP	O
with	with	IN	B-PP	O
clonidine	clonidine	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
full	full	JJ	B-NP	O
code	code	NN	I-NP	O
.	.	.	O	O

eScription	eScription	NN	B-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
4-3531847	4-3531847	CD	B-NP	O
CSSten	CSSten	NNP	I-NP	O
Tel	Tel	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
DULKIS	DULKIS	NNP	B-NP	O
,	,	,	O	O
DONALD	DONALD	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
DOSREIS	DOSREIS	NNP	B-NP	O
,	,	,	O	O
WINSTON	WINSTON	NNP	B-NP	O
JC	JC	NNP	I-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
8069129	8069129	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
3/8/06	3/8/06	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
8/27/06	8/27/06	CD	B-NP	O

